Cargando…

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment

Tumor cells manipulate the local environment in which they grow, creating a tumor microenvironment (TME) that promotes tumor survival and metastasis. The TME is an extremely complex environment rich in immunosuppressive cells and cytokines. Various methods to therapeutically target the complicated T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lihong, Chard Dunmall, Louisa S, Cheng, Zhenguo, Wang, Yaohe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157365/ https://www.ncbi.nlm.nih.gov/pubmed/35640930 http://dx.doi.org/10.1136/jitc-2021-004167

Ejemplares similares

A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020)

Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma
por: Wang, Zhizhong, et al.
Publicado: (2022)

Natural products targeting glycolysis in cancer
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
por: Sun, Yijie, et al.
Publicado: (2022)

A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
por: Wang, Na, et al.
Publicado: (2020)

Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients
por: Zhang, Na, et al.
Publicado: (2022)

Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers
por: Lan, Tianfeng, et al.
Publicado: (2021)

Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization
por: Sharp, Daniel W., et al.
Publicado: (2016)

Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene
por: Cao, Dujuan, et al.
Publicado: (2022)

Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
por: Howells, Anwen, et al.
Publicado: (2017)

Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
por: St-Cyr, Guillaume, et al.
Publicado: (2023)

Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
por: Ferguson, Mark S., et al.
Publicado: (2020)

Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy
por: Jia, Yangyang, et al.
Publicado: (2023)

A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
por: Marelli, Giulia, et al.
Publicado: (2021)

Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus
por: Wan, Peter Kok-Ting, et al.
Publicado: (2021)

OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment
por: Liu, Shiyu, et al.
Publicado: (2023)

A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
por: Ahmed, Jahangir, et al.
Publicado: (2020)

Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells
por: Liu, Ching-Hsuan, et al.
Publicado: (2023)

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime
por: Zhang, Zhe, et al.
Publicado: (2020)

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
por: Matsumura, Shuichi, et al.
Publicado: (2021)

Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
por: Zhou, Wenping, et al.
Publicado: (2023)

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022)

Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
por: Lou, Jiaying, et al.
Publicado: (2021)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
por: Ferguson, Mark S., et al.
Publicado: (2012)

Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
por: AuYeung, Amanda W. K., et al.
Publicado: (2021)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Correction: Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
Publicado: (2022)

Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment
por: Wang, Xiaoxi, et al.
Publicado: (2021)

Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
por: Park, Jee Soo, et al.
Publicado: (2022)

Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors
por: Schäfer, Simon, et al.
Publicado: (2012)

Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis
por: Tsoneva, Desislava, et al.
Publicado: (2017)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
por: DePeaux, Kristin, et al.
Publicado: (2023)

Immune responses elicited by ssRNA(−) oncolytic viruses in the host and in the tumor microenvironment
por: Bykov, Yonina, et al.
Publicado: (2023)

Immunological Aspects of Viral Oncolysis
por: Stim, Thomas B.
Publicado: (1967)

Mechanisms of Oncolysis by Paramyxovirus Sendai
por: Matveeva, O. V., et al.
Publicado: (2015)

Syrian Hamster as an Animal Model for the Study on Infectious Diseases
por: Miao, Jinxin, et al.
Publicado: (2019)

Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection
por: Weibel, Stephanie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0la4luu12bu346a5edoht4f7fq